Literature DB >> 30566746

Efficacy and safety of steroid in the prevention of esophageal stricture after endoscopic submucosal dissection: A network meta-analysis.

Jiahui Yang1, Xin Wang1, Yarui Li1, Guifang Lu1, Xinlan Lu1, Dan Guo1, Wancong Wang2, Chuan Liu2, Ye Xiao1, Nini Han1, Shuixiang He1.   

Abstract

BACKGROUND AND AIM: Even though endoscopic submucosal dissection is an important endoscopic resection technique for gastrointestinal neoplasms, there are chances that postoperative esophageal stricture might take place as a side effect. Steroid applications were reported to be effective for the prevention of stricture formation. Therefore, this study aims to evaluate the efficacy and safety of different steroid applications.
METHODS: Eligible studies published on PubMed, the Cochrane Library, Embase, Web of Science, and Chinese Biomedical Literature Database before August 2018 were reviewed. The preventions were divided as placebo/no treatment, long-term oral steroid (LOS), median-term oral steroid, short-term oral steroid, single-dose steroid injection, multiple-dose steroid injection, topical superficial steroid, steroid injection combined with oral steroid, and preemptive endoscopic balloon dilatation. The primary outcomes were postoperative esophageal stricture rate and endoscopic balloon dilatation sessions required. Complications were also analyzed.
RESULTS: A total of 19 studies were included. The network meta-results illustrated that compared with the placebo, all kinds of steroid interventions were associated with lower rates of postoperative esophageal stenosis and less number of endoscopic balloon dilatation sessions. Moreover, combined therapy was no better than single regimen therapy. No significant differences between various steroid applications in the incidence of complications were spotted during this study. Based on the results of the network and clustered ranking, LOS might be the superior prevention for postoperative stricture with satisfying efficacy.
CONCLUSION: The present study showed that LOS appears to be the optimal prevention method for postoperative stricture formation.
© 2018 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  ESD; endoscopic submucosal dissection; esophageal stricture; network meta-analysis; steroid; systematic review

Year:  2019        PMID: 30566746     DOI: 10.1111/jgh.14580

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

Review 1.  Endoscopic Management of Refractory Benign Esophageal Strictures.

Authors:  Alessandro Fugazza; Alessandro Repici
Journal:  Dysphagia       Date:  2021-03-12       Impact factor: 3.438

2.  Evaluation of human keratinocyte sheets transplanted onto porcine excised esophagus after submucosal dissection in an ex vivo model.

Authors:  Yosuke Kawai; Ryo Takagi; Takeshi Ohki; Masakazu Yamamoto; Masayuki Yamato
Journal:  Regen Ther       Date:  2020-12-10       Impact factor: 3.419

Review 3.  Esophageal regenerative therapy using cell sheet technology.

Authors:  Takeshi Ohki; Masakazu Yamamoto
Journal:  Regen Ther       Date:  2020-05-15       Impact factor: 3.419

Review 4.  Recent approach for preventing complications in upper gastrointestinal endoscopic submucosal dissection.

Authors:  Waku Hatta; Tomoyuki Koike; Hiroko Abe; Yohei Ogata; Masahiro Saito; Xiaoyi Jin; Takeshi Kanno; Kaname Uno; Naoki Asano; Akira Imatani; Atsushi Masamune
Journal:  DEN open       Date:  2021-10-31

Review 5.  Roles of Steroids in Preventing Esophageal Stricture after Endoscopic Resection.

Authors:  Yu Qiu; Ruihua Shi
Journal:  Can J Gastroenterol Hepatol       Date:  2019-04-01

6.  Comparison of endoscopic injection of botulinum toxin and steroids immediately after endoscopic submucosal dissection to prevent esophageal stricture: a prospective cohort study.

Authors:  Xiaoying Zhou; Han Chen; Meihong Chen; Chao Ding; Guoxin Zhang; Xinmin Si
Journal:  J Cancer       Date:  2021-08-02       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.